The induction of a prolonged increase in microvascular permeability by human mast cell chymase

By He S.   Walls A.F.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 91-98

Elsevier

Access to resources Recommend Favorite

Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase. 2. Investigation of the Carboxamide Portion of Spirocyclic Piperidine Amides

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 2, 2008-03 ,pp. : 116-121

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic targets in asthma: the rationale for mast cell tryptase inhibition

By Elrod K.C.   Numerof R.P.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 2, 1999-06 ,pp. : 203-212

Informa Healthcare

Access to resources Recommend Favorite

Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases

By  

Current Pharmaceutical Design, Vol. 19, Iss. 6, 2013-02 ,pp. : 1114-1125

Bentham Science Publishers

Access to resources Recommend Favorite

Mast Cell Tryptase &bgr; as a Target in Allergic Inflammation: An Evolving Story

By  

Current Pharmaceutical Design, Vol. 13, Iss. 3, 2007-01 ,pp. : 313-332

Bentham Science Publishers

Access to resources Recommend Favorite